Lv4
640 积分 2025-07-09 加入
Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice
1个月前
已完结
Biochemical assays for AID/APOBECs and the identification of AID/APOBEC inhibitors
3个月前
已关闭
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma
5个月前
已关闭
Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma
5个月前
已完结
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
5个月前
已完结
[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial
5个月前
已完结
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
5个月前
已完结
Tumor PD-L1 induces β2m ubiquitylation and degradation for cancer cell immune evasion
8个月前
已完结
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes
1年前
已完结
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes
1年前
已完结
皖公网安备34019202002308
